Sage Therapeutics (SAGE)
(Real Time Quote from BATS)
$12.54 USD
+0.25 (2.03%)
Updated Jul 22, 2024 02:48 PM ET
3-Hold of 5 3
F Value B Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC7/31/24 |
---|---|
Current Quarter | -1.66 |
EPS Last Quarter | -1.80 |
Last EPS Surprise | -10.43% |
ABR | 2.77 |
Earnings ESP
|
-6.58% |
---|---|
Current Year | -6.54 |
Next Year | -5.01 |
EPS (TTM) | -7.84 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 8.52M | 10.42M | 39.94M | 154.02M |
# of Estimates | 10 | 10 | 11 | 11 |
High Estimate | 11.05M | 15.20M | 56.79M | 584.56M |
Low Estimate | 6.79M | 7.48M | 32.00M | 52.38M |
Year ago Sales | 2.47M | 2.72M | 86.46M | 39.94M |
Year over Year Growth Est. | 245.06% | 283.01% | -53.80% | 285.59% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.66 | -1.61 | -6.54 | -5.01 |
# of Estimates | 12 | 10 | 13 | 13 |
Most Recent Consensus | -1.81 | -1.84 | -7.30 | -6.90 |
High Estimate | -1.42 | -1.32 | -5.66 | 3.59 |
Low Estimate | -1.82 | -1.84 | -7.33 | -7.53 |
Year ago EPS | -2.68 | -2.81 | -9.05 | -6.54 |
Year over Year Growth Est. | 38.06% | 42.70% | 27.73% | 23.37% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 1 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 2 | 2 |
Down Last 60 Days | 1 | 1 | 2 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.66 | -1.61 | -6.54 | -5.01 |
7 Days Ago | -1.66 | -1.61 | -6.54 | -5.01 |
30 Days Ago | -1.66 | -1.60 | -6.46 | -4.90 |
60 Days Ago | -1.69 | -1.63 | -6.53 | -5.01 |
90 Days Ago | -1.62 | -1.59 | -6.30 | -4.53 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.77 | -1.62 | -6.83 | -5.90 |
Zacks Consensus Estimate | -1.66 | -1.61 | -6.54 | -5.01 |
Earnings ESP | -6.58% | -0.56% | -4.41% | -17.69% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.80 | -0.55 | -2.81 | -2.68 | NA |
Estimate | -1.63 | -1.18 | -2.64 | -2.53 | NA |
Difference | -0.17 | 0.63 | -0.17 | -0.15 | 0.04 |
Surprise | -10.43% | 53.39% | -6.44% | -5.93% | 7.65% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more